Name
Integrating Available Medications in Primary Care for management of Fatty Liver disease
Date & Time
Thursday, December 4, 2025, 7:55 PM - 8:25 PM
Speakers


Description
- Role of GLP-1s, statins, insulin sensitizers, and upcoming MASH therapies
- Considerations for T2D, obesity, CKD, and polypharmacy
- What’s in the pipeline
- Diabetes Canada Guidelines / CanMASLD Guidelines?